MENZAGHI, BARBARA

MENZAGHI, BARBARA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 29 (tempo di esecuzione: 0.002 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple Regimen 2025 Menzaghi, BarbaraPiconi, StefaniaRusconi, StefanoRicci, Elena DelfinaBonfanti, Paolo + Article (author) -
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 2025 d'Arminio Monforte, AntonellaMonforte, A d'ArminioAntinori, SCernuschi, MMarchetti, GCGiacomelli, AGori, AMarchetti, GPerno, CFBandera, ABonora, SLai, APerno, CFPiconi, SRossotti, RRusconi, SSantoro, MMTaramasso, LTincati, CPastorino, RCernuschi, MAugello, MMenzaghi, BPan, APiconi, SMolteni, CCanavesi, GAntinori, SBandera, ABono, VCossu, MVGiacomelli, APezzati, LTincati, CBonfanti, PGentile, IBonora, S + Article (author) -
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 2025 Giacomelli, Andread'Arminio Monforte, AntonellaAntinori, SpinelloAugello, MatteoBandera, AlessandraBonfanti, PaoloBono, ValeriaBonora, StefanoCanavesi, GiadaCossu, Maria VittoriaGori, AndreaLai, AlessiaLazzarin, AdrianoMarchetti, GiuliaMenzaghi, BarbaraMoioli, Maria CristinaPerno, Carlo FedericoPezzati, LauraPiconi, StefaniaRossotti, RobertoRovito, RobertaRusconi, StefanoSantoro, CarmenSuardi, ClaudiaTaramasso, LuciaTincati, Camilla + Article (author) -
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced dimalsease: a trial emulation 2025 Giacomelli, AndreaRaimondi, AlessandroAntinori, SpinelloMarchetti, Giulia CarlaMonforte, Antonella d'ArminioMarchetti, GPerno, CFBandera, ABonora, SGiacomelli, ALapadula, GPiconi, SRusconi, SSantoro, MMTaramasso, LCernuschi, MFarinella, MAugello, MRovito, RSuardi, CMenzaghi, BPan, ASegala, DCanavesi, GCossu, MVMoioli, MCPezzati, LTincati, CBonfanti, PDi Filippo, GMastroianni, C + Article (author) -
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 2025 Antinori, SMarchetti, G CPerno, C FBandera, ABonora, Sd'Arminio Monforte, AGiacomelli, ALapadula, GPiconi, SRossotti, RRusconi, SSantoro, M MTaramasso, LPastorino, RCernuschi, MFarinella, MAugello, MRovito, RSuardi, CMenzaghi, BPan, ASegala, DCanavesi, GAntinori, SBono, VCossu, M VMoioli, M CPezzati, LTincati, CBonfanti, PDi Filippo, GMastroianni, C + Article (author) -
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir 2023 Taramasso, LuciaMenzaghi, BarbaraPiconi, StefaniaBandera, AlessandraBonfanti, Paolo + Article (author) -
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 2022 Taramasso L.Bonfanti P.Menzaghi B.Sarchi E.Angarano G.Menzaghi B.Rusconi S.Bandera A.Gori A.Motta D.Bonfanti P. + Article (author) -
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 2022 Valenti L.Pelusi S.Aghemo A.Pasulo L.Degasperi E.D'Ambrosio R.Zuccaro V.Giorgini A.Rumi M. G.Spinelli O.Colombo M. C.Menzaghi B.D'Arminio Monforte A.Bonfanti P.Lampertico P. + Article (author) -
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 2021 Bandera A.Taramasso L.d'Arminio Monforte A.Gori A.Ippolito G.Lazzarin A.Marchetti G. C.Perno C. F.Bai F.Bonora S.Lai A.Piconi S.Rossotti R.Rusconi S.Macchia M.Errico M.Manfredini M.Milano E.Suardi C.Menzaghi B.Segala D.Alessandrini A.Bonfanti P.Lazzarin A.Cannizzo E. S.Moioli M. C.Piolini R.Bernacchia D.Tincati C. + Article (author) -
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 2021 Taramasso L.Ricci E. D.Menzaghi B.Sarchi E.Rusconi S.Bandera A.Bonfanti P. + Article (author) -
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 2021 Lombardi A.Colaneri M.D'Ambrosio R.Degasperi E.Dibenedetto C.Giorgini A.Pasulo L.Spinelli O.Re T.Rumi M.Aghemo A.Lampertico P.Soffredini R.Perbellini R.Gori A.Colpani M.Manini M.Lazzaroni S.De Nicola S.Angelini Zucchetti T.Rossotti R.Colella E.Magnani C.Mena M.Caramma I.Basilico C.Biagiotti S.Mazzone A.Saladino V.Menzaghi B.Rumi M.Fanetti I.Dibenedetto C.Zermiani P.Zuin M.D'Arminio Monforte A.Capretti A.Messina E.Colombo A. E.Bonfanti P.Conforti S.Menozzi F.Gritti S.Giani P. + Article (author) -
Renal safety in 3264 HCV patients treated with DAA-based regimens : results from a large Italian real-life study 2020 Pasulo L.Giorgini A.Fanetti I.Aghemo A.Menzaghi B.Lombardi A.Spinelli O.D'Arminio Monforte A.Zuin M.Lampertico P. + Article (author) -
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 2020 Cossu M. V.Menzaghi B.Di Cristo V.Valenti D.Gori A. + Article (author) -
Comorbidities and HCV coinfection in the management of HIV+ patients: Evidence from the Italian clinical practice 2020 Menzaghi B.D'Arminio Monforte A.Croce D. + Article (author) -
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 2020 Cossu, Maria VMenzaghi, BarbaraDi Cristo, ValentinaUglietti, AlessiaRucci, FrancescoGori, Andrea + Article (author) -
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 2020 D'Arminio Monforte A.Rusconi S.Bonora S.Carini E.Da Ros V.Suardi C.Menzaghi B.Lazzarin A.Carini E.Gazzola L.Gori A.Bandera A.Mazzola G.Centonze S. + Article (author) -
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 2020 Lapadula G.Valsecchi M. G.Carriero C.Degasperi E.Pasulo L.Baiguera C.Menzaghi B.Lombardi A.Aghemo A.Rumi M. G.Valenti L.De Bona A.d'Arminio Monforte A.Bonfanti P.Perini P.Capretti A.Ciaccio A.Lampertico P. + Article (author) -
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy 2019 D'Ambrosio, R.Di Marco, V.Fabris, P.Lombardi, A.Zuin, M.Aghemo, A.Rumi, M. G.Spinelli, O.Colli, A.Menzaghi, B.Soffredini, R.Colpani, M.Gori, A.Giorgini, A.Capretti, A.Colombo, A. E.Dibenedetto, C.Lampertico, P. + Article (author) -
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 2019 Taramasso L.Menzaghi B.Bonfanti P.SARCHI, ELENAAngarano G.Menzaghi B.MASTROIANNI, ANTONIOBonfanti P.Rusconi S.Bandera A.Gori A.Motta D. + Article (author) -
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 2019 D'Ambrosio, RobertaPasulo, LuisaGatti, FedericoMenzaghi, BarbaraRumi, Maria GraziaGiorgini, AlessiaSpinelli, OmbrettaSaladino, ValeriaBonfanti, PaoloGori, AndreaLampertico, PietroAghemo, Alessio + Article (author) -